DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Visipaque (Iodine Intravascular) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Visipaque (Iodine Intravascular) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Visipaque side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-01

Patient: male

Reactions: Drug Eruption, Rash Generalised, Skin Exfoliation, Lymphopenia, Pyrexia, Purpura, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rifabutin

Ethambutol Hydrochloride

Colchicine

Tramadol HCL

Nefopam Hydrochloride (Acupan)

Visipaque
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-13
    End date: 2011-10-13

Clarithromycin



Possible Visipaque side effects in male

Reported by a physician from France on 2012-05-25

Patient: male

Reactions: Rash Generalised, Skin Exfoliation, Drug Ineffective, Adverse Drug Reaction, General Physical Health Deterioration, Purpura, Pyrexia, Hyperhidrosis, Erythema, Liver Function Test Abnormal, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clarithromycin
    Start date: 2011-11-14

Ethambutol Hydrochloride
    Administration route: Oral
    Indication: Atypical Mycobacterial Infection
    Start date: 2011-10-07
    End date: 2011-10-13

Tramadol HCL
    Administration route: Oral
    Indication: Arthralgia
    Start date: 2011-09-24
    End date: 2011-10-17

Visipaque
    Dosage: once
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-13

Rifabutin
    Administration route: Oral
    Indication: Atypical Mycobacterial Infection
    Start date: 2011-10-07
    End date: 2011-10-13

Ethambutol Hydrochloride
    Start date: 2011-11-17

Ethambutol Hydrochloride
    Start date: 2011-10-15
    End date: 2011-10-17

Colchicine
    Dosage: 3 1st day; 2 2nd + 3rd day; 1 since 4th
    Administration route: Oral
    Indication: Arthralgia
    Start date: 2011-10-04
    End date: 2011-10-17

Rifabutin
    Start date: 2011-10-15
    End date: 2011-10-17

Rifabutin
    Start date: 2011-11-20

Clarithromycin
    Administration route: Oral
    Indication: Atypical Mycobacterial Infection
    Start date: 2011-10-07
    End date: 2011-10-13

Acupan
    Administration route: Oral
    Indication: Pain
    Start date: 2011-10-03
    End date: 2011-10-07

Clarithromycin
    Start date: 2011-10-15
    End date: 2011-10-17



Possible Visipaque side effects in 49 year old male

Reported by a physician from South Africa on 2012-02-24

Patient: 49 year old male

Reactions: Chills, Pyrexia, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Visipaque



Possible Visipaque side effects in 41 year old male

Reported by a physician from South Africa on 2012-02-24

Patient: 41 year old male

Reactions: Chills, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Visipaque



Possible Visipaque side effects in 41 year old male

Reported by a physician from South Africa on 2012-02-24

Patient: 41 year old male

Reactions: General Physical Condition Abnormal, C-Reactive Protein Increased, Chills, Pyrexia, Leukocytosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Visipaque



Possible Visipaque side effects in 48 year old male

Reported by a physician from South Africa on 2012-02-24

Patient: 48 year old male

Reactions: Chills, Pyrexia, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Visipaque



Possible Visipaque side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-06

Patient: male

Reactions: Product Quality Issue, Pyrexia, Salmonella Test Positive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Visipaque



Possible Visipaque side effects in 72 year old male

Reported by a individual with unspecified qualification from China on 2011-12-01

Patient: 72 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Cerebral Infarction, Pain, Injection Site Pain, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Visipaque

Other drugs received by patient: Acetylsalicylic Acid (Aspirin) (Acetylsalicylic Acid)



Possible Visipaque side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-11-15

Patient: 60 year old female

Reactions: Renal Artery Fibromuscular Dysplasia, Arterial Disorder, Pyrexia, Headache, Serum Ferritin Increased, Renal Ischaemia, Ehlers-Danlos Syndrome, Vertebral Artery Stenosis, Chest Pain, Coronary Artery Occlusion, Vascular Pseudoaneurysm, Angiodysplasia, Ischaemic Stroke, Troponin Increased, Carotid Artery Dissection, Antinuclear Antibody Positive, Renal Artery Dissection, Transient Global Amnesia, Artery Dissection, Hypertension, Inflammation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cortivasol (Altm) (Cortivasol)
    Dosage: epidural
    Start date: 2011-03-11
    End date: 2011-03-11

Visipaque
    Dosage: 10 ml, single, dose, epidural
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-11
    End date: 2011-03-11



Possible Visipaque side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from Slovakia (Slovak Republic) on 2011-10-12

Patient: 63 year old female

Reactions: Grand MAL Convulsion, Brain Oedema, Pyrexia, Hemiparesis, Altered State of Consciousness, Ischaemic Cerebral Infarction

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Visipaque

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017